Iliomad Health Data

Compliance Solutions for Life Sciences.
Worldwide.

We provide data protection AI compliance expertise for the Life Sciences sector.

Compliance Services For Life Sciences

We help Life Sciences companies master regulatory compliance linked with data protection and AI.

Data Protection for Life Science

We provide outsourced DPO, EU Representative, and data governance services tailored to Life Sciences. Our expertise covers GDPR, HIPAA, FADP, and sector-specific requirements for health data.

AI for Life Sciences

We provide compliance expertise with the EU AI Act tailored to healthcare, pharma, and clinical research. From risk assessment to post-market monitoring, we help you innovate with confidence.

Expertise

Data governance. AI compliance. EU representation. Integrated expertise for Life Sciences

Domains

Our focus is on providing support to life sciences companies in the most innovative sectors.

Who We Work With

Biotech sponsors, HealthTech companies, CROs and the people who run them. Find the compliance path built for your industry and your role.

FAQs

Our frequently questions

What does iliomad specialize in?

iliomad provides specialized regulatory compliance and data protection services for life sciences companies. We help biotech, pharma, MedTech, and health AI companies navigate GDPR, clinical trial compliance, EU AI Act requirements, and cross-border data protection so you can focus on innovation while staying audit-ready.

How is iliomad different from law firms?

We're regulatory compliance specialists, not lawyers. While law firms provide legal opinions, iliomad delivers operational implementation. We act as your external DPO, build compliance frameworks, and prepare you for audits and due diligence practical solutions that regulators and investors expect to see working in practice.

What regulations does iliomad cover?

We provide worldwide regulatory coverage with hands-on experience in 75+ countries. Our core expertise includes GDPR for clinical trials, EU AI Act compliance, FDA data protection requirements, HIPAA, and international data transfer mechanisms (Standard Contractual Clauses, adequacy decisions). Beyond the EU and US, we handle country-specific requirements including Turkish VERBİS registration, Canadian PIPEDA, Australian Privacy Act, and jurisdiction-specific obligations across Asia, Latin America, and the Middle East.

‍

Do you work with companies in clinical trials?

Absolutely. Clinical trial compliance is core to our practice. We help sponsors, CROs, and sites navigate informed consent requirements, cross-border patient data transfers, investigator agreements, and regulatory submissions to ensure your study meets both scientific and data protection standards.

How quickly can iliomad start supporting our compliance needs?

We typically begin with an initial assessment within one week of engagement. For urgent regulatory matters—such as authority inquiries, clinical trial blockers, or due diligence preparation we can mobilize immediately to address critical compliance gaps.

How do we get started?

Contact us through our website form or email directly. We'll schedule an initial consultation to understand your regulatory landscape, identify immediate priorities, and propose a tailored engagement that fits your timeline and budget.

Latest Resources

The latest industry news, articles, and best practices from our team.

Newsletter
February 2, 2026

Newsletter #34

EU-Brazil data adequacy, ICO transfer guidance, EMA-FDA AI principles, and medical device reform.

Newsletter
January 1, 2026

Newsletter #33

Regulators advance AI rules as innovation accelerates amid governance and safety concerns

Newsletter
December 1, 2025

Newsletter #32

Privacy reforms advance; AI boosts drug discovery, mental health care, ADCs, healthspan.

Newsletter
November 1, 2025

Newsletter #31

November spotlight: global AI, privacy, and healthtech reforms driving stricter regulatory compliance worldwide.

Newsletter
October 1, 2025

Newsletter #30

From EU courts to AI in healthcare, key insights shaping data protection.

Newsletter
September 1, 2025

Newsletter #29

Our September newsletter is here — covering global regulations, AI breakthroughs in healthcare, cybersecurity threats, and the rise of wellness tech.

Newsletter
August 1, 2025

Newsletter #28

August insights: FDA cybersecurity, EU AI code, biotech breakthroughs, Episource breach alert.

Newsletter
July 1, 2025

Newsletter #27

This edition unpacks the latest regulatory shifts, including UK data adequacy, secure AI training, and the EU’s evolving stance on medical software platforms.

Newsletter
June 1, 2025

Newsletter #26

This month’s highlights span AI in health, new U.S. and EU privacy rules, and evolving data and cybersecurity regulations.

Find out how iliomad can help your company.

[Map placeholder]
Only visible in production
38.709099
-39.182035
1.6
6d17042a3425c5b3
Your message has been received!
We'll get back to you as soon as possible.
Something went wrong, please try again.